Canada markets closed

Renalytix Plc (2O9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.2080+0.0240 (+13.04%)
At close: 03:29PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-06-30
2022-06-30
2021-06-30
2020-06-30
2019-06-30
Total Revenue
2,221
3,403
2,970
1,491
0
-
Cost of Revenue
2,256
2,683
2,096
804
0
-
Gross Profit
-35
720
874
687
0
-
Operating Expenses
Research Development
11,500
14,298
14,648
10,040
4,565
-
Selling General and Administrative
21,759
28,662
39,524
15,436
5,750
-
Total Operating Expenses
33,259
42,941
54,057
33,298
10,315
-
Operating Income or Loss
-33,294
-42,221
-53,183
-32,611
-10,315
-
Interest Expense
-
-
2
3
2
20
Total Other Income/Expenses Net
-
-
-
-
-63
-
Income Before Tax
-37,478
-45,605
-45,251
-35,788
-9,844
-
Income Tax Expense
8
2
25
-4,778
0
-
Income from Continuing Operations
-37,486
-45,607
-45,276
-31,010
-9,844
-
Net Income
-37,486
-45,607
-45,276
-31,010
-9,844
-
Net Income available to common shareholders
-37,486
-45,607
-45,276
-31,010
-9,844
-
Basic EPS
-0.50
-0.55
-0.62
-0.43
-0.17
-
Diluted EPS
-0.50
-0.55
-0.67
-0.43
-0.17
-
Basic Average Shares
87,201
82,210
72,861
71,485
59,080
-
Diluted Average Shares
87,201
82,210
73,837
71,485
59,080
-